Evidence map›Paper›PMID 36506152›Full record

ArticleACS omega2022

Dehydroroyleanone as a Building Block for a Drug Delivery Platform Based on Self-Assembled Nanoparticles: Structural Studies and Chemical Modification.

Catarina García, Carlos E S Bernardes, M Fátima M Piedade, Gaia Fumagalli, Eleonora Colombo, Ana M Díaz-Lanza, Catarina P Reis, Isabel Correia, Lia Ascensão, Daniele Passarella and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Catarina GarcíaCBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, 1749-024Lisboa, Portugal.
Carlos E S BernardesCentro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, 1749-016Lisboa, Portugal.ORCID https://orcid.org/0000-0003-1490-9728
M Fátima M PiedadeCentro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, 1749-016Lisboa, Portugal.
Gaia FumagalliDipartimento di Chimica, Università Degli Studi di Milano, Via Golgi 19, 20133Milano, Italy.
Eleonora ColomboDipartimento di Chimica, Università Degli Studi di Milano, Via Golgi 19, 20133Milano, Italy.
Ana M Díaz-LanzaDepartamento de Ciencias Biomédicas (Área de Farmacología; Nuevos A̅gentes Antitumorales, Acción Tóxica Sobre Células Leucémicas, Facultad de Farmacia, Universidad de Alcalá de Henares, Ctra. Madrid-Barcelona km. 33,600, 28805Alcalá de Henares, Madrid, España.
Catarina P ReisInstituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, 1649-003Lisboa, Portugal.
Isabel CorreiaCentro de Química Estrutural, Institute of Molecular Sciences, Instituto Superior Técnico, Universidade de Lisboa, 1049-001Lisboa, Portugal.ORCID https://orcid.org/0000-0001-7096-4284
Lia AscensãoCentro de Estudos do Ambiente e do Mar (CESAM), Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016Lisbon, Portugal.
Daniele PassarellaDipartimento di Chimica, Università Degli Studi di Milano, Via Golgi 19, 20133Milano, Italy.
Manuel E Minas da PiedadeCentro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, 1749-016Lisboa, Portugal.ORCID https://orcid.org/0000-0001-7550-6952
Patrícia RijoCBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, 1749-024Lisboa, Portugal.ORCID https://orcid.org/0000-0001-7992-8343
University of Lisbon · PTUniversity of Milan · ITUniversidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

6,7-Dehydroroyleanone (DHR) is a caspase-induced cytotoxic abietane diterpene, frequently found on

Identifiers

PMID36506152
PMCPMC9730763
OpenAlexW4309825479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.